Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04215549
Other study ID # SMHC-OCD-5
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date January 2, 2020
Est. completion date October 2020

Study information

Verified date November 2020
Source Shanghai Mental Health Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to estimate the cost of obsessive-compulsive disorder in China based on the prevalence rate from a social perspective.


Description:

Obsessive-compulsive disorder(OCD) is one of relatively common mental disorders with a prevalence of 1.63% in China. OCD usually begins in adolescence or young adulthood , it will become a chronic disabling disease, if it is not treated in timeand.OCD can be so severe that it can seriously impact on some or all areas of a person's life, bring huge economic burden. At present, there is only one article on the cost of OCD in the United States in the 1990s, and this part of the data in China is blank.A cross-sectional study recruited 600 patients with OCD from 13 hospitals in eastern, western, southern, and northern China. A structured questionnaire was used for face-to-face interviewing to collect costs related to OCD. The direct costs for each patient and indirect costs ffor each patient and their caregivers were calculated . The human capital method is used to calculate indirect costs. Through weighting, the cost of OCD in China is estimated from a social perspective using a bottom-up methodology.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 2020
Est. primary completion date October 2020
Accepts healthy volunteers No
Gender All
Age group 16 Years to 65 Years
Eligibility Inclusion Criteria: - primarily diagnosed OCD meet DSM-5 critera - 16-65 years old - Get informed consent from patients Exclusion Criteria: - Concurrent neuropsychiatric diseases such as schizophrenia, which severely interfere with treatment costs - Drug abuser - Unable to understand the questionnaire

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
cross sectional study,no intervention

Locations

Country Name City State
China Shanghai Mental Health Center Shanghai Shanghai

Sponsors (13)

Lead Sponsor Collaborator
Shanghai Mental Health Center Brain Hospital Affiliated to Guangzhou Medical University, Capital Medical University, First Affiliated Hospital Xi'an Jiaotong University, Guangji Hospital Affiliated to Soochow University, Hangzhou Seventh People's Hospital, Peking University Sixth Hospital, Qingdao Mental Health Center, Qiqihar Medical University, Shandong Provincial Hospital, The First Affiliated Hospital of Kunming Medical College, the First Psychiatric Hospital of Harbin, The Second Affiliated Hospital of Xinxiang Medical College

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary obsessive-compulsive disorder related costs in China Estimating the direct and indirect Costs of Chinese OCD based on prevalence from a social perspective 1 year
Secondary Direct costs and indirect costs of consumed resources Direct costs include medical costs and transportation, food, accommodation, etc. corresponding related to clinics.Indirect costs include lost time for patients and family members due to OCD. 1 year
Secondary other costs directly associated with OCD Other medical costs and economic loss of disruptive behaviors due to OCD 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04934007 - Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder N/A
Recruiting NCT04071990 - Family Involvement in CBGT of OCD: a Randomized Controlled Trial N/A
Completed NCT02541968 - Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Recruiting NCT05391503 - Light Therapy for Obsessive-compulsive Disorder (OCD) N/A
Recruiting NCT04539951 - Pragmatic Trial of Obsessive-compulsive Disorder Phase 2
Completed NCT03416504 - Methods for Managing Intrusive Thoughts N/A
Not yet recruiting NCT06029738 - Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD N/A
Recruiting NCT02844049 - European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS N/A
Terminated NCT02909660 - What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder N/A
Completed NCT02911324 - Cannabinoid Medication for Adults With OCD Phase 1/Phase 2
Completed NCT02217995 - Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients N/A
Terminated NCT02234011 - A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder Phase 2
Withdrawn NCT01953042 - Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders N/A
Completed NCT02655926 - Deep Brain Stimulation for Severe Obsessive Compulsive Disorder N/A
Completed NCT04919785 - Deep Brain Stimulation in Severe Obsessive-compulsive Disorder N/A
Terminated NCT00758966 - Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder Phase 2
Completed NCT00742664 - Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project Phase 1/Phase 2
Completed NCT00523718 - Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder Phase 2
Completed NCT00074815 - Treatment of Obsessive Compulsive Disorder in Children Phase 3